180 related articles for article (PubMed ID: 38078907)
21. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
22. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
23. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
24. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
Xie R; Tang J; Zhu X; Jiang H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
[No Abstract] [Full Text] [Related]
25. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
Zarei M; Malekzadeh K; Omidi M; Mousavi P
Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
[TBL] [Abstract][Full Text] [Related]
27. [
Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
[TBL] [Abstract][Full Text] [Related]
28. Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.
Addison JB; Voronkova MA; Fugett JH; Lin CC; Linville NC; Trinh B; Livengood RH; Smolkin MB; Schaller MD; Ruppert JM; Pugacheva EN; Creighton CJ; Ivanov AV
Mol Cancer Res; 2021 May; 19(5):784-798. PubMed ID: 33500360
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
[TBL] [Abstract][Full Text] [Related]
30. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z
Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
[TBL] [Abstract][Full Text] [Related]
32. IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.
Sun Y; Guo G; Zhang Y; Chen X; Lu Y; Hong R; Xiong J; Li J; Hu X; Wang S; Liu Y; Zhang Z; Yang X; Nan Y; Huang Q
Cell Signal; 2024 Apr; 116():111062. PubMed ID: 38242271
[TBL] [Abstract][Full Text] [Related]
33. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer.
Gong P; Qiao F; Wu H; Cui H; Li Y; Zheng Y; Zhou M; Fan H
Cell Death Dis; 2018 Nov; 9(12):1158. PubMed ID: 30464170
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer.
Shayimu P; Yusufu A; Rehemutula A; Redati D; Jiapaer R; Tuerdi R
Technol Cancer Res Treat; 2020; 19():1533033820967475. PubMed ID: 33084522
[TBL] [Abstract][Full Text] [Related]
35. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
36. Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer.
Metge BJ; Alsheikh HAM; Kammerud SC; Chen D; Das D; Nebane NM; Bostwick JR; Shevde LA; Samant RS
Cell Death Dis; 2024 May; 15(5):322. PubMed ID: 38719798
[TBL] [Abstract][Full Text] [Related]
37. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
Belkaid A; Ouellette RJ; Surette ME
Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
[TBL] [Abstract][Full Text] [Related]
38. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
39. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma.
Yang J; Zou Y; Wu J; Chen B; Luo C; Chen X; Shen H; Luo L
Cancer Biother Radiopharm; 2023 Nov; 38(9):596-603. PubMed ID: 33085924
[No Abstract] [Full Text] [Related]
40. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
